Susan Galel

Publication Details

  • Frequency and specificity of the Trima Accel "verify WBCs" advisory: considerations for product management.

    Galel SA, Gaitan J, Yu DT, Tolentino L, Webster J, Sugasawara E, Wilson JA, Boone C, Lendio P. Transfusion. 2012; 52 (5): 995-1002

    The Trima Accel displays a "verify WBCs" message if the plateletpheresis product (PLT) may not be leukoreduced (LR). Most blood banks require sensitive white blood cell (WBC) testing of these PLTs by flow or Nageotte. We evaluated how often these PLTs were non-LR by European or US Food and Drug Administration (FDA) criteria and whether sensitive WBC testing is necessary.

    PubMedID: 22023335

Stanford Medicine Resources:

Footer Links: